Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000123 | histone acetyltransferase complex | 4 | 7 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0031248 | protein acetyltransferase complex | 3 | 7 |
GO:0032991 | protein-containing complex | 1 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140535 | intracellular protein-containing complex | 2 | 7 |
GO:1902493 | acetyltransferase complex | 4 | 7 |
GO:1902494 | catalytic complex | 2 | 7 |
GO:1990234 | transferase complex | 3 | 7 |
Related structures:
AlphaFold database: E9ACT4
Term | Name | Level | Count |
---|---|---|---|
GO:0006325 | chromatin organization | 4 | 7 |
GO:0006473 | protein acetylation | 6 | 7 |
GO:0006475 | internal protein amino acid acetylation | 7 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016043 | cellular component organization | 3 | 7 |
GO:0016570 | histone modification | 5 | 7 |
GO:0016573 | histone acetylation | 6 | 7 |
GO:0018193 | peptidyl-amino acid modification | 5 | 7 |
GO:0018205 | peptidyl-lysine modification | 6 | 7 |
GO:0018393 | internal peptidyl-lysine acetylation | 8 | 7 |
GO:0018394 | peptidyl-lysine acetylation | 7 | 7 |
GO:0019538 | protein metabolic process | 3 | 7 |
GO:0036211 | protein modification process | 4 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0043412 | macromolecule modification | 4 | 7 |
GO:0043543 | protein acylation | 5 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0071840 | cellular component organization or biogenesis | 2 | 7 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 80 | 84 | PF00656 | 0.650 |
CLV_NRD_NRD_1 | 296 | 298 | PF00675 | 0.719 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.691 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.709 |
CLV_NRD_NRD_1 | 40 | 42 | PF00675 | 0.376 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.627 |
CLV_PCSK_FUR_1 | 321 | 325 | PF00082 | 0.718 |
CLV_PCSK_KEX2_1 | 261 | 263 | PF00082 | 0.705 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.714 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.691 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.723 |
CLV_PCSK_KEX2_1 | 324 | 326 | PF00082 | 0.703 |
CLV_PCSK_KEX2_1 | 40 | 42 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.627 |
CLV_PCSK_PC1ET2_1 | 261 | 263 | PF00082 | 0.690 |
CLV_PCSK_PC7_1 | 257 | 263 | PF00082 | 0.581 |
CLV_PCSK_PC7_1 | 321 | 327 | PF00082 | 0.815 |
CLV_PCSK_SKI1_1 | 300 | 304 | PF00082 | 0.743 |
DEG_SCF_FBW7_1 | 92 | 98 | PF00400 | 0.681 |
DEG_SPOP_SBC_1 | 240 | 244 | PF00917 | 0.783 |
DEG_SPOP_SBC_1 | 97 | 101 | PF00917 | 0.653 |
DOC_CKS1_1 | 92 | 97 | PF01111 | 0.628 |
DOC_MAPK_MEF2A_6 | 46 | 55 | PF00069 | 0.619 |
DOC_PP1_RVXF_1 | 203 | 209 | PF00149 | 0.627 |
DOC_PP4_FxxP_1 | 208 | 211 | PF00568 | 0.608 |
DOC_PP4_FxxP_1 | 25 | 28 | PF00568 | 0.670 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.708 |
DOC_USP7_MATH_1 | 176 | 180 | PF00917 | 0.748 |
DOC_USP7_MATH_1 | 240 | 244 | PF00917 | 0.717 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.618 |
DOC_WW_Pin1_4 | 119 | 124 | PF00397 | 0.743 |
DOC_WW_Pin1_4 | 167 | 172 | PF00397 | 0.766 |
DOC_WW_Pin1_4 | 207 | 212 | PF00397 | 0.613 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.563 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.628 |
LIG_14-3-3_CanoR_1 | 141 | 147 | PF00244 | 0.775 |
LIG_14-3-3_CanoR_1 | 214 | 221 | PF00244 | 0.729 |
LIG_14-3-3_CanoR_1 | 238 | 246 | PF00244 | 0.681 |
LIG_14-3-3_CanoR_1 | 262 | 272 | PF00244 | 0.816 |
LIG_14-3-3_CterR_2 | 324 | 329 | PF00244 | 0.714 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.700 |
LIG_BRCT_BRCA1_1 | 143 | 147 | PF00533 | 0.774 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.548 |
LIG_FHA_1 | 137 | 143 | PF00498 | 0.658 |
LIG_FHA_1 | 277 | 283 | PF00498 | 0.740 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.519 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.653 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.546 |
LIG_SH2_CRK | 140 | 144 | PF00017 | 0.672 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.641 |
LIG_SH3_3 | 177 | 183 | PF00018 | 0.744 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.677 |
LIG_SUMO_SIM_par_1 | 88 | 94 | PF11976 | 0.672 |
LIG_TRAF2_1 | 302 | 305 | PF00917 | 0.727 |
MOD_CDK_SPxxK_3 | 207 | 214 | PF00069 | 0.608 |
MOD_CK1_1 | 119 | 125 | PF00069 | 0.554 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.687 |
MOD_CK1_1 | 194 | 200 | PF00069 | 0.679 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.621 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.778 |
MOD_CK1_1 | 281 | 287 | PF00069 | 0.779 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.640 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.611 |
MOD_CK2_1 | 222 | 228 | PF00069 | 0.630 |
MOD_CK2_1 | 263 | 269 | PF00069 | 0.590 |
MOD_Cter_Amidation | 259 | 262 | PF01082 | 0.690 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.677 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.719 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.679 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.603 |
MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.798 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.543 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.666 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.692 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.784 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.637 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.662 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.695 |
MOD_GSK3_1 | 276 | 283 | PF00069 | 0.765 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.546 |
MOD_GSK3_1 | 91 | 98 | PF00069 | 0.679 |
MOD_N-GLC_1 | 276 | 281 | PF02516 | 0.662 |
MOD_N-GLC_1 | 315 | 320 | PF02516 | 0.738 |
MOD_NEK2_1 | 234 | 239 | PF00069 | 0.698 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.638 |
MOD_PK_1 | 40 | 46 | PF00069 | 0.619 |
MOD_PKA_1 | 40 | 46 | PF00069 | 0.619 |
MOD_PKA_2 | 263 | 269 | PF00069 | 0.741 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.698 |
MOD_PKA_2 | 40 | 46 | PF00069 | 0.619 |
MOD_PKB_1 | 262 | 270 | PF00069 | 0.696 |
MOD_Plk_2-3 | 315 | 321 | PF00069 | 0.600 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.578 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.546 |
MOD_ProDKin_1 | 119 | 125 | PF00069 | 0.745 |
MOD_ProDKin_1 | 167 | 173 | PF00069 | 0.766 |
MOD_ProDKin_1 | 207 | 213 | PF00069 | 0.611 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.556 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.626 |
MOD_SUMO_for_1 | 302 | 305 | PF00179 | 0.727 |
TRG_DiLeu_BaEn_2 | 20 | 26 | PF01217 | 0.705 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.675 |
TRG_ER_diArg_1 | 262 | 265 | PF00400 | 0.682 |
TRG_ER_diArg_1 | 321 | 324 | PF00400 | 0.719 |
TRG_NES_CRM1_1 | 42 | 57 | PF08389 | 0.530 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7C1 | Leptomonas seymouri | 54% | 100% |
A0A3S7WZY7 | Leishmania donovani | 89% | 100% |
A4HF24 | Leishmania braziliensis | 76% | 100% |
E9AHB5 | Leishmania infantum | 90% | 100% |
E9AYF8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |